Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

220.16
-0.5900-0.27%
Volume:84.05K
Turnover:18.48M
Market Cap:11.53B
PE:-58.42
High:221.93
Open:221.93
Low:218.48
Close:220.75
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:0.44
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:138.43
PE(LYR):-59.79

Loading ...

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and Merck & Company (MRK)

TIPRANKS
·
May 05

Mizuho Securities Keeps Their Buy Rating on Axsome Therapeutics (AXSM)

TIPRANKS
·
May 05

Morgan Stanley Sticks to Its Hold Rating for Axsome Therapeutics (AXSM)

TIPRANKS
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Axsome Therapeutics Inc : TD Cowen Raises Target Price to $275 From $255

THOMSON REUTERS
·
May 05

Axsome Therapeutics Earnings Call Signals Aggressive Growth

TIPRANKS
·
May 05

Axsome Therapeutics management to meet with Piper Sandler

TIPRANKS
·
May 05

Axsome Therapeutics Shares Rise 10.7% After Higher Q1 Revenue

THOMSON REUTERS
·
May 05

Axsome Therapeutics price target raised to $272 from $234 at Cantor Fitzgerald

TIPRANKS
·
May 05

Axsome Therapeutics Inc : Jefferies Raises Target Price to $275 From $245

THOMSON REUTERS
·
May 04

Stock Track | Axsome Therapeutics Soars 5.03% Intraday on Strong Q1 Revenue Growth, FDA Approval and Analyst Upgrades

Stock Track
·
May 04

Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock

Benzinga Earnings
·
May 04

Deutsche Bank Adjusts Axsome Therapeutics PT to $281 From $245, Maintains Buy Rating

MT Newswires Live
·
May 04

Axsome Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 04

Axsome Therapeutics Q1 revenue rises 57%, but loss widens on rising costs

Reuters
·
May 04

Axsome Q1 FY26 net loss widens to $64.5 million; revenue rises 57% to $191.2 million

Reuters
·
May 04

Earnings Flash (AXSM) Axsome Therapeutics Posts Q1 Loss $1.26 a Share, vs. FactSet Est of $0.86 Loss

MT Newswires Live
·
May 04

Axsome Therapeutics Q1 EPS $(1.26) Misses $(0.90) Estimate, Sales $191.203M Beat $189.193M Estimate

Benzinga Earnings
·
May 04

BRIEF-Axsome Therapeutics Q1 Net Income USD -64.542 Million

Reuters
·
May 04

Axsome Therapeutics Q1 EPS USD -1.26

THOMSON REUTERS
·
May 04